[go: up one dir, main page]

SE8300495L - Forbettringar av eller i samband med nasala farmaceutiska kompositioner - Google Patents

Forbettringar av eller i samband med nasala farmaceutiska kompositioner

Info

Publication number
SE8300495L
SE8300495L SE8300495A SE8300495A SE8300495L SE 8300495 L SE8300495 L SE 8300495L SE 8300495 A SE8300495 A SE 8300495A SE 8300495 A SE8300495 A SE 8300495A SE 8300495 L SE8300495 L SE 8300495L
Authority
SE
Sweden
Prior art keywords
connection
pharmaceutical compositions
nasal pharmaceutical
ciliary function
nasal
Prior art date
Application number
SE8300495A
Other languages
English (en)
Other versions
SE8300495D0 (sv
SE454402B (sv
Inventor
J-R Kiechel
F Acezat-Mispelter
D Plas
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8300495D0 publication Critical patent/SE8300495D0/sv
Publication of SE8300495L publication Critical patent/SE8300495L/sv
Publication of SE454402B publication Critical patent/SE454402B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8300495A 1982-02-01 1983-01-31 Nasalt administrerbar farmaceutisk komposition innehallande en ergotpeptidalkaloid samt ett xantin SE454402B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01

Publications (3)

Publication Number Publication Date
SE8300495D0 SE8300495D0 (sv) 1983-01-31
SE8300495L true SE8300495L (sv) 1983-08-02
SE454402B SE454402B (sv) 1988-05-02

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8300495A SE454402B (sv) 1982-02-01 1983-01-31 Nasalt administrerbar farmaceutisk komposition innehallande en ergotpeptidalkaloid samt ett xantin

Country Status (27)

Country Link
JP (1) JPS58134017A (sv)
AT (1) AT385656B (sv)
AU (1) AU565613B2 (sv)
BE (1) BE895750A (sv)
CA (1) CA1197783A (sv)
CH (1) CH653555A5 (sv)
DE (1) DE3302949A1 (sv)
DK (1) DK164771C (sv)
ES (1) ES519450A0 (sv)
FI (1) FI81258C (sv)
FR (1) FR2539994B1 (sv)
GR (1) GR81320B (sv)
HK (1) HK59989A (sv)
HU (1) HU191512B (sv)
IE (1) IE54532B1 (sv)
IL (1) IL67822A (sv)
IT (1) IT1197558B (sv)
KE (1) KE3888A (sv)
LU (1) LU84613A1 (sv)
MY (1) MY8700766A (sv)
NL (1) NL192325C (sv)
NZ (1) NZ203117A (sv)
PH (1) PH22198A (sv)
PT (1) PT76166B (sv)
SE (1) SE454402B (sv)
SG (1) SG34389G (sv)
ZA (1) ZA83673B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
JP7317020B2 (ja) * 2018-01-05 2023-07-28 インペル ファーマシューティカルズ インコーポレイテッド 精密嗅覚デバイスによるジヒドロエルゴタミンの鼻腔内送達

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
FR2387035A1 (fr) * 1977-04-12 1978-11-10 Cassenne Lab Sa Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
DE2831728C2 (de) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Arzneimittel zur Behandlung von Kopfschmerzen

Also Published As

Publication number Publication date
AU565613B2 (en) 1987-09-24
FI830245L (fi) 1983-08-02
DK38183A (da) 1983-08-02
FR2539994B1 (fr) 1986-10-10
IE54532B1 (en) 1989-11-08
LU84613A1 (fr) 1983-09-08
FI830245A0 (fi) 1983-01-25
JPS58134017A (ja) 1983-08-10
NL192325C (nl) 1997-06-04
IL67822A (en) 1988-02-29
NL192325B (nl) 1997-02-03
AT385656B (de) 1988-05-10
DK164771B (da) 1992-08-17
SE8300495D0 (sv) 1983-01-31
GR81320B (sv) 1984-12-11
FI81258B (fi) 1990-06-29
ATA30383A (de) 1987-10-15
SG34389G (en) 1989-09-22
NZ203117A (en) 1986-12-05
CH653555A5 (de) 1986-01-15
FI81258C (sv) 1990-10-10
IT8347646A1 (it) 1984-08-01
AU1085083A (en) 1983-08-11
ES8502865A1 (es) 1985-02-01
IE830187L (en) 1983-08-01
ES519450A0 (es) 1985-02-01
DK164771C (da) 1992-12-28
CA1197783A (en) 1985-12-10
PH22198A (en) 1988-06-28
KE3888A (en) 1989-09-01
IT8347646A0 (it) 1983-02-01
ZA83673B (en) 1984-09-26
DE3302949A1 (de) 1983-08-11
BE895750A (fr) 1983-08-01
MY8700766A (en) 1987-12-31
PT76166A (en) 1983-02-01
HK59989A (en) 1989-08-04
IL67822A0 (en) 1983-06-15
SE454402B (sv) 1988-05-02
DE3302949C2 (sv) 1992-05-21
JPH0253406B2 (sv) 1990-11-16
FR2539994A1 (fr) 1984-08-03
NL8300325A (nl) 1983-09-01
PT76166B (en) 1986-02-04
IT1197558B (it) 1988-12-06
DK38183D0 (da) 1983-01-31
HU191512B (en) 1987-02-27

Similar Documents

Publication Publication Date Title
ATE61050T1 (de) Pyridazinamine wirksam gegen viren.
FI935273A0 (fi) En farmaceutisk komposition innnehaollande ett definierat lipidsystem
NZ195568A (en) Guanidine derivatives and pharmaceutical compositions
MY101791A (en) New benzimidazole derivatives
SE441179B (sv) Nya cyklopropankarboxylsyror med polyhalogenerad substituent, sett for framstellning derav samt anvendning derav i pesticidkompositioner
DE3872635D1 (de) Pentamidin enthaltende pharmazeutische zusammensetzungen.
IT8468241A0 (it) Derivati del triptofano farmaceuti camente attivi e composizioni farmaceutiche che li contengono
NZ210633A (en) Glycerol derivatives and pharmaceutical compositions thereof
DE3068803D1 (en) The use of 2-phenyltetralin derivatives, or heterocyclic analogues, in medicine and pharmaceutical compositions containing them
PH13921A (en) Pharmacologically active pyrimidine derivatives and compositions thereof
IT1205337B (it) Derivati amminometil-benzenici eteroaril-sostituiti ad attivita' regolatrice del ritmo cardiaco e composizioni farmaceutiche che li contengono
IE781032L (en) Pharmaceutical compositions
ZA812088B (en) Derivative of saccharide and physiologically active agent containing the same
NZ184678A (en) Pyrimidine derivatives and pharmaceutical compositions
FI843560A7 (sv) Analoger av mevalonolaktoner och deras derivat, förfarande för deras framställning, dessa innehållande farmaceutiska föreningar och deras användning som farmaceutiska ämnen.
DE3675876D1 (de) Appetit mildernde und gegen gastritis wirksame zusammensetzung.
JPS565465A (en) Benzimidazole derivative* its manufacture and medicinal composition of same as active component
NZ184766A (en) Alkylphenyl ethers and thioethers and pharmaceutical compositions
JPS5767518A (en) Radiosensitizing agent or agent for increasing effect of radiomimetic substance
SE8300495L (sv) Forbettringar av eller i samband med nasala farmaceutiska kompositioner
ZA773979B (en) Pharmaceutically active benzamine compounds and compositions
GB2021409A (en) Pharmaceutical composition
NZ184102A (en) Derivatives of benzenesulphonylurea,and pharmaceutical compositions
NZ185296A (en) Corticoids and pharmaceutical compositions
BE888525A (fr) Nucleoside de la classe des desazapurines, compositions en contenant et leur application en medecine,

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8300495-2

Format of ref document f/p: F

NUG Patent has lapsed